Eliasson E - Search Results

1

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

Yasar U, Bennet AM, Eliasson E, Lundgren S, Wiman B, De Faire U, Rane A. Yasar U, et al. Among authors: eliasson e. Pharmacogenetics. 2003 Dec;13(12):715-20. doi: 10.1097/00008571-200312000-00002. Pharmacogenetics. 2003. PMID: 14646690

2

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

Yasar U, Lundgren S, Eliasson E, Bennet A, Wiman B, de Faire U, Rane A. Yasar U, et al. Among authors: eliasson e. Biochem Biophys Res Commun. 2002 Nov 22;299(1):25-8. doi: 10.1016/s0006-291x(02)02592-5. Biochem Biophys Res Commun. 2002. PMID: 12435384

3

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.

Yasar U, Forslund-Bergengren C, Tybring G, Dorado P, Llerena A, Sjöqvist F, Eliasson E, Dahl ML. Yasar U, et al. Among authors: eliasson e. Clin Pharmacol Ther. 2002 Jan;71(1):89-98. doi: 10.1067/mcp.2002.121216. Clin Pharmacol Ther. 2002. PMID: 11823761 Clinical Trial.

4

Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes.

Lundblad MS, Stark K, Eliasson E, Oliw E, Rane A. Lundblad MS, et al. Among authors: eliasson e. Biochem Biophys Res Commun. 2005 Feb 25;327(4):1052-7. doi: 10.1016/j.bbrc.2004.12.116. Biochem Biophys Res Commun. 2005. PMID: 15652503

5

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

Yasar U, Eliasson E, Dahl ML, Johansson I, Ingelman-Sundberg M, Sjöqvist F. Yasar U, et al. Among authors: eliasson e. Biochem Biophys Res Commun. 1999 Jan 27;254(3):628-31. doi: 10.1006/bbrc.1998.9992. Biochem Biophys Res Commun. 1999. PMID: 9920790

6

Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase.

Sandberg M, Yasar U, Strömberg P, Höög JO, Eliasson E. Sandberg M, et al. Among authors: eliasson e. Br J Clin Pharmacol. 2002 Oct;54(4):423-9. doi: 10.1046/j.1365-2125.2002.01660.x. Br J Clin Pharmacol. 2002. PMID: 12392591 Free PMC article.

7

The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotype.

Sandberg M, Johansson I, Christensen M, Rane A, Eliasson E. Sandberg M, et al. Among authors: eliasson e. Drug Metab Dispos. 2004 May;32(5):484-9. doi: 10.1124/dmd.32.5.484. Drug Metab Dispos. 2004. PMID: 15100169

8

Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomes.

Toda T, Eliasson E, Ask B, Inotsume N, Rane A. Toda T, et al. Among authors: eliasson e. Basic Clin Pharmacol Toxicol. 2009 Nov;105(5):327-32. doi: 10.1111/j.1742-7843.2009.00453.x. Epub 2009 Aug 6. Basic Clin Pharmacol Toxicol. 2009. PMID: 19663817 Free article.

9

Angiotensin II Receptor Blockers Inhibit the Generation of Epoxyeicosatrienoic Acid from Arachidonic Acid in Recombinant CYP2C9, CYP2J2 and Human Liver Microsomes.

Senda A, Mukai Y, Hayakawa T, Kato Y, Eliasson E, Rane A, Toda T, Inotsume N. Senda A, et al. Among authors: eliasson e. Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):239-245. doi: 10.1111/bcpt.12789. Epub 2017 May 10. Basic Clin Pharmacol Toxicol. 2017. PMID: 28374982 Free article.

10

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro.

Yasar U, Eliasson E, Forslund-Bergengren C, Tybring G, Gadd M, Sjöqvist F, Dahl ML. Yasar U, et al. Among authors: eliasson e. Eur J Clin Pharmacol. 2001 Dec;57(10):729-35. doi: 10.1007/s00228-001-0376-7. Eur J Clin Pharmacol. 2001. PMID: 11829203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters